Documents

A list of downloadable documents created during development.

Diagnostics consultation: 2

Atrial fibrillation and heart valve disease: self-monitoring coagulation status using point-of-care coagulometers (the CoaguChek XS system and the INRatio2 PT/INR monitor): consultation comments with EAG responses

Atrial fibrillation and heart valve disease: self-monitoring coagulation status using point-of-care coagulometers (the CoaguChek XS system and the INRatio2 PT/INR monitor): equalities impact assessment

Point-of-care coagulometers (the CoaguChek XS system and the INRatio2 PT/INR monitor) for self-monitoring coagulation status in people on long-term vitamin K antagonist therapy who have atrial fibrillation or heart valve disease: diagnostics consultation

Point-of-care coagulometers (the CoaguChek XS system and the INRatio2 PT/INR monitor): Diagnostics Assessment Report

Point-of-care coagulometers (the CoaguChek XS system and the INRatio2 PT/INR monitor): overview

Point-of-care coagulometers (the CoaguChek XS system and the INRatio2 PT/INR monitor): Collated DAR comments table with EAG responses

Self-monitoring coagulometers (CoaguChek XS system, INRatio2 PT/INR monitor and ProTime Microcoagulation system), for self-testing or self-managing coagulation status in people with atrial fibrillation or heart valve disease for whom long-term vitamin K antagonist therapy is intended: final scope - DAP16

Self-monitoring coagulometers (CoaguChek XS system, INRatio2 PT/INR monitor and ProTime Microcoagulation system), for self-testing or self-managing coagulation status in people for whom long-term vitamin K antagonist therapy is intended: final protocol - DAP16

Self-monitoring coagulometers (CoaguChek XS system, INRatio2 PT/INR monitor and ProTime Microcoagulation system), for self-testing or self-managing coagulation status in people for whom long-term vitamin K antagonist therapy is intended: list of specialist committee members - DAP16